| D011247 |
Pregnancy |
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. |
Gestation,Pregnancies |
|
| D004963 |
Estrenes |
Unsaturated derivatives of the ESTRANES with methyl groups at carbon-13, with no carbon at carbon-10, and with no more than one carbon at carbon-17. They must contain one or more double bonds. |
19-Norandrostenes,19 Norandrostenes |
|
| D005260 |
Female |
|
Females |
|
| D005313 |
Fetal Death |
Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH. |
Fetal Mummification,Fetal Demise,Death, Fetal,Deaths, Fetal,Demise, Fetal,Fetal Deaths,Mummification, Fetal |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000019 |
Abortifacient Agents |
Chemical substances that interrupt pregnancy after implantation. |
Abortifacient Effect,Abortifacient Effects,Abortifacients,Contraceptive Agents, Postconception,Agents, Abortifacient,Agents, Postconception Contraceptive,Effect, Abortifacient,Effects, Abortifacient,Postconception Contraceptive Agents |
|
| D000021 |
Abortifacient Agents, Steroidal |
Steroidal compounds with abortifacient activity. |
Steroid Abortifacients,Abortifacients, Steroid,Agents, Steroidal Abortifacient,Steroidal Abortifacient Agents |
|
| D000032 |
Abortion, Therapeutic |
Abortion induced to save the life or health of a pregnant woman. (From Dorland, 28th ed) |
Therapeutic Abortion,Abortions, Therapeutic,Therapeutic Abortions |
|
| D000328 |
Adult |
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. |
Adults |
|
| D015735 |
Mifepristone |
A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME. |
Mifegyne,Mifeprex,Mifégyne,R-38486,R38486,RU-38486,RU-486,ZK-98296,ZK98296,R 38486,RU 38486,RU 486,RU38486,RU486,ZK 98296 |
|